Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AMS May Enter Permanent Birth-Control Market Via Merger Or License

This article was originally published in The Gray Sheet

Executive Summary

Conceptus has less than three weeks to decide whether to purchase Ovion or to allow the transcervical sterilization device developer to merge with American Medical Systems

You may also be interested in...



Cytyc’s Purchase Of Adiana Opens Door To Female Contraception Market

Cytyc could gain PMA approval by year-end for its newly acquired, non-incisional alternative to tubal ligation for permanent female contraception, according to the company

Cytyc’s Purchase Of Adiana Opens Door To Female Contraception Market

Cytyc could gain PMA approval by year-end for its newly acquired, non-incisional alternative to tubal ligation for permanent female contraception, according to the company

Promotion Pact Broadens Conceptus’ Market For Birth-Control Device

Conceptus is redoubling efforts to sell non-incisional birth control to physician offices after failing to acquire Ovion

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022222

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel